Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): A randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Understanding the HydraFacial Treatment HydraFacial is a non-invasive facial treatment that combines cleansing, exfoliation, extraction, hydration, and antioxidant protection in a four-step process
The standard approach starts at 2.5 mg weekly for four weeks, then increases to 5 mg weekly
The medication typically suppresses appetite within the first four weeks of use
Using it regularly is an easy way to add flavor while gently supporting appetite balance